These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 608723)
1. Immunoglobulin studies in malaria and kala-azar infections. Ghose AC; Chowdhury AB Indian J Med Res; 1977 Oct; 66(4):566-9. PubMed ID: 608723 [No Abstract] [Full Text] [Related]
2. Immunological response in Indian kala-azar. Aikat BK; Pathania AG; Sehgal S; Bhattacharya PK; Dutta U; Pasricha N; Singh S; Parmar RS; Sahaya S; Prasad LS Indian J Med Res; 1979 Oct; 70():583-91. PubMed ID: 396234 [No Abstract] [Full Text] [Related]
3. B lymphocyte population and immunoglobulins in Indian kala-azar in response to chemotherapy. Neogy AB; Nandy A; Dastidar BG; Chowdhury AB Acta Trop; 1986 Sep; 43(3):237-44. PubMed ID: 2877550 [TBL] [Abstract][Full Text] [Related]
4. Measurement of anti-leishmanial serum antibody titre in Indian kala-azar. Sinha AN; Srivastava SN; Gupta AK; Shrama MC; Prasad LS J Commun Dis; 1985; 17(1 Suppl):100-6. PubMed ID: 3913693 [No Abstract] [Full Text] [Related]
5. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India. Mathur P; Samantaray J; Chauhan NK Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998 [TBL] [Abstract][Full Text] [Related]
6. Immunological features of kala-azar. Rezai HR; Ardehali SM; Amirhakimi G; Kharazmi A Am J Trop Med Hyg; 1978 Nov; 27(6):1079-83. PubMed ID: 310248 [TBL] [Abstract][Full Text] [Related]
7. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit. Sundar S; Sahu M; Mehta H; Gupta A; Kohli U; Rai M; Berman JD; Murray HW Clin Infect Dis; 2002 Sep; 35(5):581-6. PubMed ID: 12173133 [TBL] [Abstract][Full Text] [Related]
8. Hematological and serological aspects of Mediterranean kala-azar in infancy and childhood. Li Volti S; Fischer A; Musumeci S Acta Trop; 1980 Dec; 37(4):351-65. PubMed ID: 6110325 [TBL] [Abstract][Full Text] [Related]
9. Lymphocyte subsets in kala-azar. Sciotto A; Russo-Mancuso G; Zinna CM; Comisi FF; Sciannaca RM; Schiliro G Ann Allergy; 1989 Oct; 63(4):343-6. PubMed ID: 2802272 [TBL] [Abstract][Full Text] [Related]
10. Lymphocyte changes in Mediterranean kala-azar. Musumeci S; SchilirĂ² G; Li Volti S; Sciotto A Trans R Soc Trop Med Hyg; 1981; 75(2):304-5. PubMed ID: 7303141 [No Abstract] [Full Text] [Related]
11. [Kala-azar associated with vivax malaria and cryptococcosis. A case report with a clinicopathological study and statistical review on kala-azar in Japan]. Kawakita Y; Takahama M; Horie K; Maeda K; Miyagawa K Kumamoto Igakkai Zasshi; 1967 Nov; 41(11):1054-65. PubMed ID: 4872735 [No Abstract] [Full Text] [Related]
12. Epidemiology of visceral leishmaniasis in India. Bora D Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321 [TBL] [Abstract][Full Text] [Related]
16. [Parasite burden and immune response in kala-azar]. Ben Rachid MS; Ben Said M; Kamoun S; Charmot G Bull Soc Pathol Exot Filiales; 1987; 80(2):218-29. PubMed ID: 3301032 [TBL] [Abstract][Full Text] [Related]
19. Sero-epidemiological study of kala-azar in a village of Varanasi district, India. Kumar R; Pai K; Kumar P; Pandey HP; Sundar S Trop Med Int Health; 2006 Jan; 11(1):41-8. PubMed ID: 16398754 [TBL] [Abstract][Full Text] [Related]
20. Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh. Rahman KM; Islam S; Rahman MW; Kenah E; Ghalib CM; Zahid MM; Maguire J; Rahman M; Haque R; Luby SP; Bern C Clin Infect Dis; 2010 Jan; 50(1):73-6. PubMed ID: 19951168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]